Lenalidomide Differentially Modifies the Genomic Profile and miRNA Expression of Mesenchymal Stromal Cells From Patients with 5q-Syndrome

被引:0
|
作者
Muntion, Sandra
Santamaria, Carlos
Roson, Beatriz [2 ]
Romo, Carlos
Lopez-Villar, Olga
Carrancio, Soraya
Sanchez-Guijo, Fermin M.
Diez-Campelo, Maria
Sarasquete, Maria-Eugenia
de las Rivas, Javier [2 ]
Gonzalez, Marcos
San Miguel, Jesus F. [1 ]
del Canizo, Maria-Consuelo
机构
[1] Hosp Univ Salamanca, Ctr Invest, Salamanca, Spain
[2] Univ Salamanca, Ctr Invest Canc, E-37008 Salamanca, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1627 / 1628
页数:2
相关论文
共 50 条
  • [1] LENALIDOMIDE MODIFIES THE BEHAVIOR OF MESENCHYMAL STROMAL CELLS (MSC) FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES WITH 5Q-(MDS-5Q-)
    Muntion, S.
    Diez-Campelo, M.
    Rojas, S.
    Santamaria, C. M.
    Ramos, T. L.
    Preciado, S.
    Caballero, J. C.
    Redondo, A.
    Sanchez-Abarca, L. I.
    Sanchez-Guijo, F.
    Canizo, M. D.
    HAEMATOLOGICA, 2014, 99 : 80 - 80
  • [2] Genomic aberrations observed in mesenchymal stem cells from 5q-syndrome could be involved in the pathophysiology of the disease
    Santamaria, C.
    Lopez-Villar, O.
    Hernandez-Campo, P.
    Sanchez-Guijo, F.
    del Canizo, C.
    LEUKEMIA RESEARCH, 2009, 33 : S38 - S39
  • [3] Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome
    Lopez-Villar, O.
    Garcia, J. L.
    Sanchez-Guijo, F. M.
    Robledo, C.
    Villaron, E. M.
    Hernandez-Campo, P.
    Lopez-Holgado, N.
    Diez-Campelo, M.
    Barbado, M. V.
    Perez-Simon, J. A.
    Hernandez-Rivas, J. M.
    San-Miguel, J. F.
    del Canizo, M-C
    LEUKEMIA, 2009, 23 (04) : 664 - 672
  • [4] Both Expanded and Uncultured Mesenchymal Stem Cells from MDS Patients Are Genomically Abnormal, Showing a Specific Genetic Profile for the 5q-Syndrome
    Lopez Villar, Olga
    LuiS Garcia, Juan
    Sanchez Guijo, Fermin M.
    Robledo, Cristina
    Hernandez Campo, Pilar
    Diez Campelo, Maria
    Muntion, Sandra
    Perez Simon, Jose Antonio
    San Miguel, J. F.
    Consuelo Del Canizo, MariA
    BLOOD, 2008, 112 (11) : 582 - 583
  • [5] Gene expression profiling of CD34+ cells in patients with the 5q-syndrome
    Boultwood, Jacqueline
    Pellagatti, Andrea
    Cattan, Helen
    Lawrie, Charles H.
    Giagounidis, Aristoteles
    Malcovati, Luca
    Della Porta, Matteo G.
    Jaedersten, Martin
    Killick, Sally
    Fidler, Carrie
    Cazzola, Mario
    Hellstroem-Lindberg, Eva
    Wainscoat, James S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (04) : 578 - 589
  • [6] High Resolution Molecular Analysis of 5q-Syndrome Patients at Diagnosis and Following Lenalidomide Therapy
    Mohamedali, Azim M.
    Lea, Nicholas
    Twine, Natalie
    Gaken, Joop
    Chelliah, Rajani
    Westwood, Nigel
    Mufti, Ghulam J.
    BLOOD, 2008, 112 (11) : 90 - 90
  • [7] GENE EXPRESSION PROFILE OF HUMAN MESENCHYMAL STROMAL CELLS FROM MYELODYSPLASTIC SYNDROME PATIENTS AND HEALTHY CONTROLS
    Boada, M.
    Otatti, C.
    Straneo, P.
    Spangenberg, L.
    Grille, S.
    LEUKEMIA RESEARCH, 2023, 128
  • [8] Defective expression of the dihydrofolate reductase gene in patients with 5q-syndrome
    Invernizzi, R
    Comincini, S
    Travaglino, E
    Facoetti, A
    Ramajoli, I
    Nano, R
    HAEMATOLOGICA, 2003, 88 (04) : 471 - 474
  • [9] MESENCHYMAL STEM CELLS FROM LOW-GRADE MDS AND HEALTHY DONORS DISPLAYED DISTINCTIVE GENE EXPRESSION PROFILE PATTERNS, WITH 5Q-SYNDROME AS AN INTERMEDIATE SUBGROUP
    Santamaria, C.
    Lopez-Villar, O.
    Muntion, S.
    Carrancio, S.
    Sanchez-Guijo, F.
    San Miguel, J.
    Del Canizo, M. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 129 - 130
  • [10] LENALIDOMIDE INFLUENCES THE FUNCTIONAL CAPACITY OF MESENCHYMAL STROMAL CELLS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
    Ferrer, R.
    Wobus, M.
    Ehninger, G.
    Bornhaeuser, M.
    Platzbecker, U.
    HAEMATOLOGICA, 2012, 97 : 136 - 136